Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Ali Shojaie, Silvia Rota, Ahmad Al Khleifat, K Ray Chaudhuri & Ammar Al-Chalabi. (2023) Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson’s disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 562-571.
Read now
Read now
Paulos Gebrehiwet, Lisa Meng, Stacy A. Rudnicki, Phil Sarocco, Jenny Wei, Andrew A. Wolff, Adriano Chiò, Jinsy A. Andrews, Angela Genge, Carlayne E. Jackson, Noah Lechtzin, Timothy M. Miller & Jeremy M. Shefner. (2023) MiToS and King’s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 304-310.
Read now
Read now
Angela Genge & Adriano Chio. (2023) The future of ALS diagnosis and staging: where do we go from here?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:3-4, pages 165-174.
Read now
Read now
Jaime Luna, Philippe Couratier, Sanae Lahmadi, Géraldine Lautrette, Andrea Fontana, Rosanna Tortelli, Giancarlo Logroscino, Pierre-Marie Preux, Massimilano Copetti & Marin Benoit. (2021) Comparison of the ability of the King’s and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:7-8, pages 478-485.
Read now
Read now
Nur Adilah Abdul Aziz, Tsun-Haw Toh, Ee-Chin Loh, David Paul Capelle, Khean-Jin Goh, Lydia Abdul Latif, Tze-Yang Chung & Nortina Shahrizaila. (2021) The utility of ALS staging systems in a multi-ethnic patient cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 341-349.
Read now
Read now
Ahmad Al Khleifat, Rubika Balendra, Ton Fang & Ammar Al-Chalabi. (2021) Intuitive Staging Correlates With King’s Clinical Stage. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:5-6, pages 336-340.
Read now
Read now
Rubika Balendra, Ahmad Al Khleifat, Ton Fang & Ammar Al-Chalabi. (2019) A standard operating procedure for King’s ALS clinical staging. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 159-164.
Read now
Read now
Nimish J. Thakore, Brittany R. Lapin, Tyler G. Kinzy & Erik P. Pioro. (2018) Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 483-494.
Read now
Read now
Peter Bede & Orla Hardiman. (2018) Longitudinal structural changes in ALS: a three time-point imaging study of white and gray matter degeneration. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:3-4, pages 232-241.
Read now
Read now
Articles from other publishers (44)
J. Cassereau, E. Bernard, S. Genestet, M. Chebbah, S. Le Clanche, A. Verschueren & P. Couratier. (2023) Management of amyotrophic lateral sclerosis in clinical practice: Results of the expert consensus using the Delphi methodology. Revue Neurologique 179:10, pages 1134-1144.
Crossref
Crossref
Juliette Ortholand, Pierre-François Pradat, Sophie Tezenas du Montcel & Stanley Durrleman. (2023) Interaction of sex and onset site on the disease trajectory of amyotrophic lateral sclerosis. Journal of Neurology 270:12, pages 5903-5912.
Crossref
Crossref
Hristelina Ilieva, Mithila Vullaganti & Justin Kwan. (2023) Advances in molecular pathology, diagnosis, and treatment of amyotrophic lateral sclerosis. BMJ, pages e075037.
Crossref
Crossref
Christina Martin Schaff, Jerome E. Kurent, Sherry Kolodziejczak, Michelle Milic, Laura A. Foster & Ambereen K. Mehta. (2023) Neuroprognostication for Patients with Amyotrophic Lateral Sclerosis: An Updated, Evidence-Based Review. Seminars in Neurology 43:05, pages 776-790.
Crossref
Crossref
Katie Stenson, Lasair O'Callaghan, Jennifer Mellor, Jack Wright, Gregor Gibson, Lucy Earl, Sophie Barlow & Christina Nicole Fournier. (2023) Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey. Journal of the Neurological Sciences 452, pages 120764.
Crossref
Crossref
Veria Vacchiano, Andrea Mastrangelo, Corrado Zenesini, Simone Baiardi, Patrizia Avoni, Barbara Polischi, Sabina Capellari, Fabrizio Salvi, Rocco Liguori & Piero Parchi. (2023) Elevated plasma p-tau181 levels unrelated to Alzheimer’s disease pathology in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 94:6, pages 428-435.
Crossref
Crossref
Diogo F. Soares, Rui Henriques, Marta Gromicho, Mamede de Carvalho & Sara C. Madeira. (2023) Triclustering-based classification of longitudinal data for prognostic prediction: targeting relevant clinical endpoints in amyotrophic lateral sclerosis. Scientific Reports 13:1.
Crossref
Crossref
G. Milella, A. Introna, D.M. Mezzapesa, E. D’Errico, A. Fraddosio, M. Ucci, S. Zoccolella & I.L. Simone. (2023) Clinical Profiles and Patterns of Neurodegeneration in Amyotrophic Lateral Sclerosis: A Cluster-Based Approach Based on MR Imaging Metrics. American Journal of Neuroradiology 44:4, pages 403-409.
Crossref
Crossref
Anna Nigri, Eleonora Dalla Bella, Stefania Ferraro, Jean Paul Medina Carrion, Greta Demichelis, Enrica Bersano, Monica Consonni, Antje Bischof, Mario Stanziano, Sara Palermo, Giuseppe Lauria, Maria Grazia Bruzzone & Nico Papinutto. (2023) Cervical spinal cord atrophy in amyotrophic lateral sclerosis across disease stages. Annals of Clinical and Translational Neurology 10:2, pages 213-224.
Crossref
Crossref
Gizem Gül Koc, Fatih Safa Eranay, Ali Kokangul & Filiz Koc. (2023) Determining the Significance Weights of ALSFRS-R Items Using Analytic Hierarchy Process. Neurological Sciences and Neurophysiology 40:2, pages 88-94.
Crossref
Crossref
André Maier, Matthias Boentert, Peter Reilich, Simon Witzel, Susanne Petri, Julian Großkreutz, Moritz Metelmann, Paul Lingor, Isabell Cordts, Johannes Dorst, Daniel Zeller, René Günther, Tim Hagenacker, Torsten Grehl, Susanne Spittel, Joachim Schuster, Albert Ludolph & Thomas Meyer. (2022) ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale. Neurological Research and Practice 4:1.
Crossref
Crossref
Eva L Feldman, Stephen A Goutman, Susanne Petri, Letizia Mazzini, Masha G Savelieff, Pamela J Shaw & Gen Sobue. (2022) Amyotrophic lateral sclerosis. The Lancet 400:10360, pages 1363-1380.
Crossref
Crossref
Peter Bede, Aizuri Murad, Jasmin Lope, Orla Hardiman & Kai Ming Chang. (2022) Clusters of anatomical disease-burden patterns in ALS: a data-driven approach confirms radiological subtypes. Journal of Neurology 269:8, pages 4404-4413.
Crossref
Crossref
Stephen A Goutman, Orla Hardiman, Ammar Al-Chalabi, Adriano Chió, Masha G Savelieff, Matthew C Kiernan & Eva L Feldman. (2022) Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. The Lancet Neurology 21:5, pages 480-493.
Crossref
Crossref
Ana Londral. (2022) Assistive Technologies for Communication Empower Patients With ALS to Generate and Self-Report Health Data. Frontiers in Neurology 13.
Crossref
Crossref
Antonella Romano, Emahnuel Trosi Lopez, Marianna Liparoti, Arianna Polverino, Roberta Minino, Francesca Trojsi, Simona Bonavita, Laura Mandolesi, Carmine Granata, Enrico Amico, Giuseppe Sorrentino & Pierpaolo Sorrentino. (2022) The progressive loss of brain network fingerprints in Amyotrophic Lateral Sclerosis predicts clinical impairment. NeuroImage: Clinical 35, pages 103095.
Crossref
Crossref
Leonor Cerdá Alberich, Juan Francisco Vázquez-Costa, Amadeo Ten-Esteve, Miguel Mazón & Luis Martí-Bonmatí. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers
507
548
.
Alessandro Introna, Giammarco Milella, Antonella Morea, Maria Ucci, Angela Fraddosio, Stefano Zoccolella, Eustachio D'Errico & Isabella Laura Simone. (2021) King's college progression rate at first clinical evaluation: A new measure of disease progression in amyotrophic lateral sclerosis. Journal of the Neurological Sciences 431, pages 120041.
Crossref
Crossref
Nuno Jorge Lamas & Laurent Roybon. (2021) Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient. Frontiers in Drug Discovery 1.
Crossref
Crossref
Özden O. Dalgıç, Haoran Wu, F. Safa Erenay, Mustafa Y. Sir, Osman Y. Özaltın, Brian A. Crum & Kalyan S. Pasupathy. (2021) Mapping of critical events in disease progression through binary classification: Application to amyotrophic lateral sclerosis. Journal of Biomedical Informatics 123, pages 103895.
Crossref
Crossref
Eleonora Dalla Bella, Enrica Bersano, Giovanni Antonini, Giuseppe Borghero, Margherita Capasso, Claudia Caponnetto, Adriano Chiò, Massimo Corbo, Massimiliano Filosto, Fabio Giannini, Rossella Spataro, Christian Lunetta, Jessica Mandrioli, Sonia Messina, Maria Rosaria Monsurrò, Gabriele Mora, Nilo Riva, Romana Rizzi, Gabriele Siciliano, Vincenzo Silani, Isabella Simone, Gianni Sorarù, Valeria Tugnoli, Lorenzo Verriello, Paolo Volanti, Roberto Furlan, John M Nolan, Emmanuelle Abgueguen, Irene Tramacere & Giuseppe Lauria. (2021) The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial. Brain 144:9, pages 2635-2647.
Crossref
Crossref
Seong-il Oh, Jin-Sung Park, Jung-Joon Sung & Seung Hyun Kim. (2021) Clinical Scales Used in Motor Neuron Disease. Journal of the Korean Neurological Association 39:2 Suppl, pages 77-86.
Crossref
Crossref
Ruojie He, Minying Zheng, Ling Lian & Xiaoli Yao. (2021) Milano–Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis. Cells 10:5, pages 1220.
Crossref
Crossref
Maria Elena Cicardi, Lara Marrone, Mimoun Azzouz & Davide Trotti. (2021) Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis. The EMBO Journal 40:10.
Crossref
Crossref
Vincent Grollemund, Gaétan Le Chat, Marie-Sonia Secchi-Buhour, François Delbot, Jean-François Pradat-Peyre, Peter Bede & Pierre-François Pradat. (2020) Manifold learning for amyotrophic lateral sclerosis functional loss assessment. Journal of Neurology 268:3, pages 825-850.
Crossref
Crossref
Edward Poluyi, Eghosa Morgan, Charles Poluyi, Chibuikem Ikwuegbuenyi & Grace Imaguezegie. (2021) Examining the Relationship between Concussion and Neurodegenerative Disorders: A Review on Amyotrophic Lateral Sclerosis (ALS) and Alzheimer’s Disease (AD). Indian Journal of Neurotrauma.
Crossref
Crossref
Federico Ranieri, Sara Mariotto, Raffaele Dubbioso & Vincenzo Di Lazzaro. (2021) Brain Stimulation as a Therapeutic Tool in Amyotrophic Lateral Sclerosis: Current Status and Interaction With Mechanisms of Altered Cortical Excitability. Frontiers in Neurology 11.
Crossref
Crossref
Ammar Al-Chalabi, Adriano Chiò, Charlotte Merrill, Gerry Oster, Rebecca Bornheimer, Wendy Agnese & Stephen Apple. (2021) Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19. Journal of Neurology, Neurosurgery & Psychiatry 92:2, pages 165-171.
Crossref
Crossref
Matthew C. Kiernan, Steve Vucic, Kevin Talbot, Christopher J. McDermott, Orla Hardiman, Jeremy M. Shefner, Ammar Al-Chalabi, William Huynh, Merit Cudkowicz, Paul Talman, Leonard H. Van den Berg, Thanuja Dharmadasa, Paul Wicks, Claire Reilly & Martin R. Turner. (2020) Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nature Reviews Neurology 17:2, pages 104-118.
Crossref
Crossref
Nimish J. Thakore, Erik P. Pioro, Belinda L. Udeh, Brittany R. Lapin & Irene L. Katzan. (2020) A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole. Value in Health 23:12, pages 1543-1551.
Crossref
Crossref
Simone P. Norris, Marie-France N. Likanje & Jinsy A. Andrews. (2020) Amyotrophic lateral sclerosis: update on clinical management. Current Opinion in Neurology 33:5, pages 641-648.
Crossref
Crossref
Umberto Manera, Andrea Calvo, Margherita Daviddi, Antonio Canosa, Rosario Vasta, Maria Claudia Torrieri, Maurizio Grassano, Maura Brunetti, Sandra D'Alfonso, Lucia Corrado, Fabiola De Marchi, Cristina Moglia, Fabrizio D'Ovidio, Gabriele Mora, Letizia Mazzini & Adriano Chiò. (2020) Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based study. Journal of Neurology, Neurosurgery & Psychiatry 91:3, pages 291-297.
Crossref
Crossref
Robert Steinbach, Meerim Batyrbekova, Nayana Gaur, Annika Voss, Beatrice Stubendorff, Thomas E. Mayer, Christian Gaser, Otto W. Witte, Tino Prell & Julian Grosskreutz. (2020) Applying the D50 disease progression model to gray and white matter pathology in amyotrophic lateral sclerosis. NeuroImage: Clinical 25, pages 102094.
Crossref
Crossref
Alan Moore, Carolyn A. Young & Dyfrig A. Hughes. (2019) Health Utilities and Costs for Motor Neurone Disease. Value in Health 22:11, pages 1257-1265.
Crossref
Crossref
Klaudia Kukulka, Karla T. Washington, Raghav Govindarajan & David R. Mehr. (2019) Stakeholder Perspectives on the Biopsychosocial and Spiritual Realities of Living With ALS: Implications for Palliative Care Teams. American Journal of Hospice and Palliative Medicine® 36:10, pages 851-857.
Crossref
Crossref
P. Corcia, S. Beltran, G. Lautrette, S. Bakkouche & P. Couratier. (2019) Staging amyotrophic lateral sclerosis: A new focus on progression. Revue Neurologique 175:5, pages 277-282.
Crossref
Crossref
Rangariroyashe Hannah Chipika, Eoin Finegan, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2019) Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS. Frontiers in Neurology 10.
Crossref
Crossref
Yana Yunusova, Emily K. Plowman, Jordan R. Green, Carolina Barnett & Peter Bede. (2019) Clinical Measures of Bulbar Dysfunction in ALS. Frontiers in Neurology 10.
Crossref
Crossref
Christopher CrockfordJudith NewtonKatie LonerganTheresa ChiweraTom BoothSiddharthan ChandranShuna ColvilleMark HeverinIain MaysSuvankar PalNiall PenderMarta Pinto-GrauRatko RadakovicChristopher E. ShawLaura StephensonRobert SwinglerAlice VajdaAmmar Al-ChalabiOrla HardimanSharon Abrahams. (2018) ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 91:15.
Crossref
Crossref
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2018) Clinical Staging of Amyotrophic Lateral Sclerosis in Chinese Patients. Frontiers in Neurology 9.
Crossref
Crossref
Mary Kay Floeter, Laura E Danielian, Laura E Braun & Tianxia Wu. (2018)
Longitudinal diffusion imaging across the
C9orf72
clinical spectrum
. Journal of Neurology, Neurosurgery & Psychiatry 89:1, pages 53-60.
Crossref
Crossref
Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M. Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J. Shaw, Zachary Simmons & Leonard H. van den Berg. (2017) Amyotrophic lateral sclerosis. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Sarah Martin, Ahmad Al Khleifat & Ammar Al-Chalabi. (2017) What causes amyotrophic lateral sclerosis?. F1000Research 6, pages 371.
Crossref
Crossref
Ton Fang, Felix Jozsa & Ammar Al-Chalabi. 2017. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders. Nonmotor Parkinson’s: The Hidden Face - Management and the Hidden Face of Related Disorders
1409
1441
.